Abstract
Most new low molecular weight chemical entities in pharmaceutical developments suffer from a low aqueous solubility, making oral delivery challenging. Despite the numerous formulation efforts that can be investigated, research especially on amorphous drugs and formulations appears to be a useful approach. Whilst few drugs can be converted to an amorphous form on their own, due to their physical stability, the use of amorphous solid dispersions, i.e., the dissolution of drug molecules into (amorphous) polymers is increasingly used. However, certain shortcomings of these polymers based amorphous solid dispersions, such as a low drug load and a usually high hygroscopicity, still necessitate the investigation of alternative approaches. One such approach is the use of co-amorphous systems, i.e., the combination of initially crystalline low molecular weight drugs and excipients. Usually, here, a 1:1 molar ratio is used, but this may not be the optimal mixing ratio. In this presentation, work on investigating the optimal ratio between drug and co-former will be presented and critically discussed.
Highlights
Whilst few drugs can be converted to an amorphous form on their own, due to a too physical stability, the use of amorphous solid dispersions, i.e. the dissolution of drug molecules into polymers is increasingly used
Certain shortcoming of these polymers based amorphous solid dispersions, such as a low drug load and a usually high hygroscopicity; still necessitate the investigation of alternative approaches. One such approach is the use of co-amorphous systems, i.e. to combination of initially crystalline low molecular weight drugs and excipients
Work on investigating to optimal ratio between drug and co-former will be presented and critically discussed
Summary
Most new low molecular weight chemical entities in pharmaceutical developments suffer 8 from a low aqueous solubility, making oral delivery challenging.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
